Gattefossé, an international supplier of specialty ingredients and formulation solutions for the cosmetic and pharmaceutical industries, has officially opened its new production plant in Lufkin, Texas, as part of its global expansion strategy.
The inauguration ceremony was attended by local and national authorities, including Congressman Pete Sessions and Mayor Mark Hicks, as well as Gattefossé executives, customers, partners, employees, and community members.
## Strategic Reinforcement in North America
The new plant in Texas specializes in lipid-based excipients and aims to expand Gattefossé's production capacity in North America, a region that plays a key role in both the cosmetic and pharmaceutical industries. The plant seeks to ensure more robust supply chains, faster turnaround times, and customer proximity, while maintaining the group's high quality standards.
Gattefossé, founded in 1880 and headquartered in France, has been operating in the United States since 1982, with offices in Paramus, New Jersey, and strengthened its presence in 2017 with a technical center of excellence. The new facility in Lufkin completes its industrial footprint on three continents, along with its main plant near Lyon, France, and the operation in Singapore.
Responsible Investment and Certifications
This project represents the most significant investment in Gattefossé's history, conceived as a long-term commitment to its customers. In March 2025, the plant already obtained ISO 9001, EFfCI GMP, and EXCiPACT certifications, which recognize its rigorous approach to quality, safety, and regulatory compliance in the manufacture of cosmetic and pharmaceutical ingredients. The site was designed according to the criteria of the LEED (Leadership in Energy and Environmental Design) seal, seeking to minimize its environmental footprint through energy efficiency and sustainable practices.